Jonsson Comprehensive Cancer Center: Carcinoma trials
The registry lists 19 Carcinoma studies with Jonsson Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 0 have results posted.
Early Phase 1 2Phase 1 5Phase 2 11No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyTerminatedNCT04928820Phase 2
- BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver CancerTerminatedNCT04777708Early Phase 1
- Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell CancerWithdrawnNCT04603365Phase 2
- Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerTerminatedNCT04279561Phase 1
- Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deletedTerminatedNCT04185311Phase 1
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell CarcinomaTerminatedNCT04106362Phase 2
- 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate CancerCompletedNCT04050215Phase 2
- Pembrolizumab in Treating Participants With Recurrent Ovarian CancerActive, not recruitingNCT03732950Phase 2
- Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell CanerTerminatedNCT03618134Phase 1/2
- Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand TherapyWithdrawnNCT03596710Not applicable
- Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerTerminatedNCT03128619Phase 1
- Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate CancerActive, not recruitingNCT02881242Phase 2
- Compassionate Use of MitoGel in Upper Tract Urothelial CarcinomaNo longer availableNCT02701023
- MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver CancerCompletedNCT02683200Early Phase 1
- Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
- Autologous Dendritic Cells in Treating Patients With Metastatic Kidney CancerCompletedNCT01826877Phase 1
- Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver CancerCompletedNCT01624285Phase 2
- A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 ExpressionCompletedNCT01536743Phase 2
- Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2